The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.

Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.

SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, reports ...

We are excited to add a second hospital customer, which is our first since we transitioned to a direct sales model earlier this month. Under this new model, SeaStar Medical recognizes 100% of revenue ...

A new drug combination could help breast cancer ... Described by scientists as "potentially transformative," this breakthrough therapy could offer new hope to those affected by this challenging ...

Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced the availability of the world’s first guide for the ...

Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence ... published details of its new AI drug discovery model, named "Enchant".

LONDON : Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial ... published details of its new AI drug discovery model, named "Enchant".

New Delhi: NovoCure, a US-based company, recently received FDA approval for its wearable device to treat metastatic cancer using Tumor Treating Fields (TTFields) technology. This non-invasive ...

In the meantime, it's published a comprehensive list of devices getting the open beta and when each is expected to receive it. So let's dive in. The stable version "will be tuned accordingly based ...